Sign inJoin waitlistJoin the waitlist

Sabine Mueller

Professor · University of California (San Francisco) School of Medicine

Credentials: · · ·

History

University of California (San Francisco) School of Medicine
Present

University of California-San Francisco
2009–2010
Child Neurology
University of California-San Francisco
2008–2009
Neurology
University of California-San Francisco
2006–2008
Preliminary Pediatrics
Massachusetts General Hospital
2005–2006
Harvard Medical School
2001–2005
1995: MS, University of Hamburg, Germany
1995
University

Research

The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression
Genes & Development · 2013 · 576 citations
Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma
Nature Medicine · 2014 · 379 citations
Pediatric high-grade glioma: biologically and clinically in need of new thinking
Review · Neuro-Oncology · 2017 · 304 citations

Cassie Kline
51 papers · 3 as a fellow
Daphne Haas-Kogan
48 papers
Michael Prados
37 papers
Nalin Gupta
34 papers
CK
Carl Koschmann
26 papers
Anuradha Banerjee
25 papers
Pratiti Bandopadhayay
23 papers
Ali Nabavizadeh
21 papers
David Solomon
21 papers · 1 as a fellow
Benjamin Kann
20 papers · 20 as a resident
Joanna Phillips
18 papers
Roger Packer
18 papers

Grants

Phase 0/1 Trial of ONC206 - A Novel Imipridone for Children with Diffuse Midline Gliomas and Recurrent Malignant Brain Tumors
National Cancer Institute · R01
Contact PI · $2.4M · University of California, San Francisco
2022–2028

Clinical trials

Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)
Principal investigator · Not yet recruiting · Phase 1, Phase 2
Sabine Mueller, MD, PhD
2027–2035
Isotretinoin vs. Doxycycline for Acneiform Rash in Patients Receiving Drugs That Target the MAPK Pathway
Principal investigator · Not yet recruiting · Phase 2
University of California, San Francisco
2026–2030
Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease
Principal investigator · Recruiting · Phase 1, Phase 2
Sabine Mueller, MD, PhD
2026–2031
Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)
Principal investigator · Recruiting · Phase 2
Sabine Mueller, MD, PhD
2026–2036